US Stock MarketDetailed Quotes
PHGEW BIOMX INC C/WTS 16/10/2024 (TO PUR COM)
- 0.000
- 0.0000.00%
15min DelayClose Sep 26 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.000Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.01952wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.518Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
About BIOMX INC C/WTS 16/10/2024 (TO PUR COM) Company
BiomX, Inc. operates as a clinical-stage microbiome company, which engages in the development of both natural and engineered phage cocktails designed to target and destroy harmful bacteria in chronic diseases, such as cystic fibrosis and atopic dermatitis. Its product pipelines include BX004 and BX005, which are treatments for cystic fibrosis and atopic dermatitis respectively. The company was founded in March 2015 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolPHGEW
Company NameBIOMX INC C/WTS 16/10/2024 (TO PUR COM)
Listing DateDec 14, 2018
Founded2015
CEOMr. Jonathan Solomon
MarketPink Market
Employees71
Fiscal Year Ends12-31
Address708 Quince Orchard Road,Suite 205
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20878
Websitehttp://www.biomx.com
Company Executives
- Name
- Position
- Salary
- Jonathan Solomon
- Director and Chief Executive Officer
- 1.12M
- Dr. Merav Bassan, PhD
- Chief Development Officer
- 590.93K
- Marina Wolfson
- Senior Vice President, Finance and Operations, Principal Accounting Officer and Chief Financial Officer
- 428.26K
- Assaf Oron
- Chief Business Officer
- --
- Dr. Russell Greig
- Chairman of the Board
- 161.58K
- Jonathan S. Leff
- Director
- --
- Dr. Jesse Goodman, M.D.,M.P.H.
- Director
- --
- Gregory Merril
- Director
- --
- Susan Blum
- Independent Director
- --
- Edward Williams
- Independent Director
- 8.79K
- Dr. Alan C. Moses, F.A.C.P.,M.D.
- Independent Director
- 81.43K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data